Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 2052

1.

Partial cystectomy for muscle invasive urothelial carcinoma of the bladder: a contemporary review of the M. D. Anderson Cancer Center experience.

Kassouf W, Swanson D, Kamat AM, Leibovici D, Siefker-Radtke A, Munsell MF, Grossman HB, Dinney CP.

J Urol. 2006 Jun;175(6):2058-62.

PMID:
16697803
2.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
3.

Partial cystectomy: a contemporary review of the Memorial Sloan-Kettering Cancer Center experience and recommendations for patient selection.

Holzbeierlein JM, Lopez-Corona E, Bochner BH, Herr HW, Donat SM, Russo P, Dalbagni G, Sogani PC.

J Urol. 2004 Sep;172(3):878-81.

PMID:
15310988
4.

Long-term results of selective partial cystectomy for invasive urothelial bladder carcinoma.

Smaldone MC, Jacobs BL, Smaldone AM, Hrebinko RL Jr.

Urology. 2008 Sep;72(3):613-6. doi: 10.1016/j.urology.2008.04.052. Epub 2008 Jun 13.

PMID:
18554696
5.

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S, Skinner E, Bochner B, Thangathurai D, Mikhail M, Raghavan D, Skinner DG.

J Clin Oncol. 2001 Feb 1;19(3):666-75.

PMID:
11157016
6.

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.

Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.

J Urol. 2006 Dec;176(6 Pt 1):2414-22; discussion 2422.

PMID:
17085118
7.

Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.

Boudreaux KJ Jr, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Chang SS.

J Urol. 2009 Feb;181(2):540-5; discussion 546. doi: 10.1016/j.juro.2008.10.038. Epub 2008 Dec 13.

PMID:
19084855
8.

The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.

Solsona E, Iborra I, Rubio J, Casanova J, Almenar S.

BJU Int. 2004 Dec;94(9):1258-62.

9.

Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.

Zhang M, Tao R, Zhang C, Shen Z.

Urology. 2010 Oct;76(4):902-7. doi: 10.1016/j.urology.2010.05.007. Epub 2010 Aug 14.

PMID:
20709377
10.

Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience.

Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP.

Cancer. 2007 Aug 15;110(4):764-9.

11.

[Radical cystectomy in the treatment of bladder cancer always in due time?].

May M, Braun KP, Richter W, Helke C, Vogler H, Hoschke B, Siegsmund M.

Urologe A. 2007 Aug;46(8):913-9. German.

PMID:
17676301
12.

[Analysis of 34 cases of infiltrating carcinoma of the bladder treated exclusively with partial cystectomy (part 1)].

Escudero Barrilero A, Fernández Fernández E, Jiménez Cidre M, Maganto Pavón E, Mayayo Dehesa T, Rodríguez Rodríguez R, Galvis San Juan F, Burgos Revilla FJ.

Arch Esp Urol. 1996 May;49(4):349-64. Review. Spanish.

PMID:
8754191
13.

Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.

Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.

J Urol. 2007 Dec;178(6):2308-12; discussion 2313. Epub 2007 Oct 22.

PMID:
17936804
14.

Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients.

Stein JP, Clark P, Miranda G, Cai J, Groshen S, Skinner DG.

J Urol. 2005 Apr;173(4):1163-8.

PMID:
15758728
15.

Comparison of American Joint Committee on Cancer pathologic stage T3a versus T3b urothelial carcinoma: analysis of patient outcomes.

Boudreaux KJ Jr, Chang SS, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA Jr, Clark PE.

Cancer. 2009 Feb 15;115(4):770-5. doi: 10.1002/cncr.24110.

16.

Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.

Solsona E, Iborra I, Ricos JV, Monros JL, Rubio J, Almenar S.

J Urol. 2002 May;167(5):2007-11.

PMID:
11956428
17.

The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer.

Clark PE, Stein JP, Groshen SG, Miranda G, Cai J, Lieskovsky G, Skinner DG.

J Urol. 2004 Oct;172(4 Pt 1):1342-7.

PMID:
15371837
18.
20.

Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.

Ma B, Li H, Zhang C, Yang K, Qiao B, Zhang Z, Xu Y.

Eur J Surg Oncol. 2013 Oct;39(10):1150-6. doi: 10.1016/j.ejso.2013.04.006. Epub 2013 May 27.

PMID:
23721764
Items per page

Supplemental Content

Write to the Help Desk